Skip to main content
Log in

Posterior Reversible Encephalopathy Syndrome: Nitroglycerine a Friend or a Foe?

  • Case Report
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Posterior reversible encephalopathy syndrome (PRES) refers to a clinico-radiological entity with characteristic features on neuroimaging and rapid onset of nonspecific symptoms including headache, seizure, altered consciousness and visual disturbance. It is a neurotoxic state in response to the acute changes in blood pressure leading to vasogenic oedema. It is often but not always associated with hypertension. However, control blood pressure is one of the mainstays of management in such cases. Nitroglycerine (NTG) is a potent vasodilator and is one of the drugs for treatment of hypertensive emergencies. It is found to worsen the cerebral oedema in PRES which is considered due to failure of cerebral blood pressure autoregulation. Here, we report two such cases where patients with PRES deteriorated with NTG infusion. However, the neurological condition of the patients improved drastically the next day. NTG could have further enhanced vasodilation, thus aggravating developing PRES, after autoregulation was lost because of high blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Legriel S, Pico F, Azoulay E. Understanding posterior reversible encephalopathy syndrome. In: Annual update in intensive care and emergency medicine. Berlin: Springer; 2011. pp 631–653.

  2. Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003;29:2323–6.

    Article  Google Scholar 

  3. Poma S, Delmonte MP, Gigliuto C, et al. Management of posterior reversible syndrome in preeclamptic women. Case Rep ObstetGynecol. 2014;2014:928079.

    CAS  Google Scholar 

  4. Finsterer J, Schlager T, Kopsa W, et al. Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES). Neurology. 2003;61(5):715–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sairem Mangolnganbi Chanu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Case report

The case report involves human participants.

Informed Consent

Informed consent was obtained (no personal data are presented; only clinical data).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dr. Sairem Mangolnganbi Chanu, MS, Department of Obstetrics and Gynaecology, JIPMER, India; Dr. Priyanka BC, MBBS, Department of Obstetrics and Gynaecology, JIPMER, India; Dr. Dasari Papa, MS, Department of Obstetrics and Gynaecology, JIPMER, India; Dr Samarjit Dey, MD, Department of Anaesthesiology, Pain and Critical Care, AIIMS Raipur, Chhattisgarh, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chanu, S.M., Priyanka, B.C., Papa, D. et al. Posterior Reversible Encephalopathy Syndrome: Nitroglycerine a Friend or a Foe?. J Obstet Gynecol India 71, 437–439 (2021). https://doi.org/10.1007/s13224-020-01411-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-020-01411-8

Keywords

Navigation